Women with pathogenic germline variants in the BRCA1 or BRCA2 gene have an increased lifetime risk of breast cancer (BC) and ovarian cancer (OC), compared to the general female population, with cancer occurring about twenty years earlier than the sporadic forms. The gene discussed is BRCA2; the disease is breast cancer.